Monzon v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided February 8, 2022·No. 17-1055·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 17-1055V (not to be published)

************************* ROSA MONZON, *

*

Petitioner, * Chief Special Master Corcoran

*

v. *

* Filed: January 14, 2022 SECRETARY OF HEALTH AND * HUMAN SERVICES, *

*

Respondent. *

*

*************************

Joseph Vuckovich, Maglio Christopher & Toale, P.A., Washington, DC, for Petitioner

Dhairya Jani, U.S. Dep’t of Justice, Washington, DC, for Respondent

DECISION GRANTING IN PART ATTORNEY’S FEES AND COSTS 1

On August 4, 2017, Rosa Monzon filed a petition seeking compensation under the National Vaccine Injury Compensation Program (the “Vaccine Program”). 2 The Petition alleged that Ms. Monzon develop polymyalgia rheumatica (“PMR”) after receipt of the tetanus diphtheriaacellular -pertussis (“Tdap”) vaccine on April 12, 2016. See Petition (“Pet.”) at 2. Petitioner’s diagnosis was subsequently changed to rheumatoid arthritis (“RA”), and RA was the asserted injury in this case. Ex. 13 at 2; Petitioner’s Prehearing Brief at 1. An Entitlement Decision was filed on June 2, 2021, finding that Petitioner did not meet her burden in showing by a

1 Because this Decision contains a reasoned explanation for my actions in this case, it must be posted on the United States Court of Federal Claims website, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). As provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”). Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix).

preponderance of evidence that Petitioner likely experienced RA, that the Tdap vaccine could cause RA, or that it did so in this case. Decision, dated June 2, 2021, at 1–2 (ECF No. 52) (“Decision”). The Decision was not appealed, and judgment has entered in the case.

Petitioner has now filed a motion for a final award of attorney’s fees and costs. Motion, dated December 30, 2021 (ECF No. 56). Petitioner requests a total of $156,691.18 in attorney’s fees and costs for the work of four attorneys and fifteen paralegals at Maglio Christopher & Toale, P.A., performed between June 2016 and December 2021. ECF No. 56-1 at 61–62. Respondent reacted to the fees request on January 6, 2022. See Response, January 6, 2022 (ECF No. 57). Respondent is satisfied the statutory requirements for an award of fees and costs have been met, and defers the calculation of the amount to be awarded to my discretion. Id. at 2–3. Petitioner filed a reply on January 6, 2022, arguing that Respondent’s position is overly burdensome by forcing the Court to serve as the inquisitor and fact finder. See Reply, dated January 6, 2022. ECF No. 58 at 2–4. Nevertheless, Petitioner argues that she has met the burden of establishing reasonable fees and costs in requested amount. Id. at 4–5.

For the reasons set forth below, I hereby GRANT IN PART Petitioner’s motion, awarding fees and costs in the total amount of $149,306.81.

ANALYSIS

I. Petitioner’s Claim had Reasonable Basis

Although the Vaccine Act only guarantees a reasonable award of attorney’s fees and costs to successful petitioners, a special master may also award fees and costs in an unsuccessful case if: (1) the “petition was brought in good faith”; and (2) “there was a reasonable basis for the claim for which the petition was brought.” Section 15(e)(1). I have in prior decisions set forth at length the criteria to be applied when determining if a claim possessed “reasonable basis” sufficient for a fees award. See, e.g., Sterling v. Sec’y of Health & Hum. Servs., No. 16-551V, 2020 WL 549443, at *4 (Fed. Cl. Spec. Mstr. Jan. 3, 2020). Importantly, establishing reasonable basis does not automatically entitle an unsuccessful claimant to fees, but is instead a threshold obligation; fees can still thereafter be limited, if unreasonable, or denied entirely.

A claim’s reasonable basis 3 must be demonstrated through some objective evidentiary showing. Cottingham v. Sec’y of Health & Hum. Servs., 971 F.3d 1337, 1344 (Fed. Cir. 2020) (citing Simmons v. Sec’y of Health & Hum. Servs., 875 F.3d 632, 635 (Fed. Cir. 2017)). This

3 Because this claim’s good faith is not in dispute, I do not include a discussion of the standards applicable to that fees prong.

objective inquiry is focused on the claim—counsel’s conduct is irrelevant (although it may bulwark good faith). Simmons, 875 F.3d at 635. Reasonable basis inquiries are not static—they evaluate not only what was known at the time the petition was filed, but also take into account what is learned about the evidentiary support for the claim as the matter progresses. Perreira v. Sec’y of Health & Hum. Servs., 33 F.3d 1375, 1377 (Fed. Cir. 1994) (upholding the finding that a reasonable basis for petitioners’ claims ceased to exist once they had reviewed their expert's opinion, which consisted entirely of unsupported speculation).

The standard for reasonable basis is lesser (and thus inherently easier to satisfy) than the preponderant standard applied when assessing entitlement, as cases that fail can still have sufficient objective grounding for a fees award. Braun v. Sec’y of Health & Hum. Servs., 144 Fed. Cl. 72, 77 (2019). The Court of Federal Claims has affirmed that “[r]easonable basis is a standard that petitioners, at least generally, meet by submitting evidence.” Chuisano v. Sec’y of Health & Hum. Servs., 116 Fed. Cl. 276, 287 (Fed. Cl. 2014) (internal quotations omitted) (affirming special master). The factual basis and medical support for the claim is among the evidence that should be considered. Carter v. Sec’y of Health & Hum. Servs., 132 Fed. Cl. 372, 378 (Fed. Cl. 2017). Under the Vaccine Act, special masters have “maximum discretion” in applying the reasonable basis standard. See, e.g., Silva v. Sec’y of Health & Hum. Servs., 108 Fed. Cl. 401, 401–02 (Fed. Cl. 2012). 4

Petitioner’s claim was ultimately unsuccessful, but I find there was sufficient objective basis for it to entitle her to a fees and costs award. Even though the evidence best supported preclinical RA as the proper diagnosis, Petitioner was able to offer a number of reliable evidentiary items supportive of the RA diagnosis. For example, the presence of the anti-CCP antibodies, which Petitioner showed through a positive anti-CCP antibody test, is a significant factor in diagnosing RA. Although Petitioner did not preponderantly establish that the Tdap vaccine can cause RA, in light of the extremely lenient standard that governs reasonable basis determinations, a final award of fees and costs in this matter is permissible. And because I find no reason otherwise to deny a fees award, I will allow one herein.

II. Calculation of Fees

Determining the appropriate amount of the fees award is a two-part process. The first part involves application of the lodestar method - “multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.” Avera v. Sec’y of Health & Hum. Servs., 515 F.3d 1343, 1347–48 (Fed. Cir. 2008) (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). The second part involves adjusting the lodestar calculation up or down to take relevant factors into

Free access — add to your briefcase to read the full text and ask questions with AI

Monzon v. Secretary of Health and Human Services, (uscfc 2022).

Monzon v. Secretary of Health and Human Services (Monzon v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related